Zobrazeno 1 - 10
of 22 183
pro vyhledávání: '"HBsAg"'
Publikováno v:
Virology Journal, Vol 21, Iss 1, Pp 1-10 (2024)
Abstract Background A multivariate predictive model was constructed using baseline and 12-week clinical data to evaluate the rate of clearance of hepatitis B surface antigen (HBsAg) at the 48-week mark in patients diagnosed with chronic hepatitis B w
Externí odkaz:
https://doaj.org/article/dd579c960819459a8c411fe01f09d2ba
Publikováno v:
Virology Journal, Vol 22, Iss 1, Pp 1-12 (2025)
Abstract Aim Metabolic dysfunction-associated steatotic disease (MASLD) and chronic hepatitis B (CHB) are prevalent liver disorders. Ongoing discussions investigate the impact of MASLD on the therapeutic outcomes of CHB. Methods A cohort of 320 CHB p
Externí odkaz:
https://doaj.org/article/7a823ec419a54cca9b92cca7aba9494e
Autor:
Pornjarim Nilyanimit, Nasamon Wanlapakorn, Preeyaporn Vichaiwattana, Lakkhana Wongsrisang, Sirapa Klinfueng, Nungruthai Suntronwong, Wichan Bhunyakitikorn, Piyada Angsuwatcharakon, Chaninan Sonthichai, Narong Thawinwisan, Pichet Puedkuntod, Sunsanee Phattharasrivongchai, Parichaya Loprakhon, Watcharanan Tinnaitorn, Thawatchai Luankaew, Sasithorn Vinothai, Somjet Chaijaroen, Pornsawan Meechin, Chalermpol Pongpichit, Yong Poovorawan
Publikováno v:
Scientific Reports, Vol 15, Iss 1, Pp 1-10 (2025)
Abstract This study aimed to evaluate the impact of Thailand’s hepatitis B virus (HBV) National Program Immunization (NPI), 32 years post-implementation, on infection rates and immunity in various age groups. A cross-sectional study involved 6,068
Externí odkaz:
https://doaj.org/article/91087d2d80cf4d7e93f905e246f86329
Publikováno v:
BMC Public Health, Vol 25, Iss 1, Pp 1-10 (2025)
Abstract Background Hepatitis B virus (HBV) surface antigen (HBsAg) seroprevalence was high before the national vaccine policy was introduced in Taiwan, indicating significant HBV infection rates. The success of the HBV immunization program and other
Externí odkaz:
https://doaj.org/article/df5af43ae1c54081a48f87eca26bfb21
Autor:
Lina Wu, Jiadi Lai, Qiumin Luo, Yeqiong Zhang, Chaoshuang Lin, Dongying Xie, Youming Chen, Hong Deng, Zhiliang Gao, Liang Peng, Wenxiong Xu
Publikováno v:
Liver Research, Vol 8, Iss 3, Pp 179-187 (2024)
Background and aim: Few studies have reported hepatitis B surface antigen (HBsAg) kinetics after nucleos(t)ide analog (NA) discontinuation in patients with noncirrhotic chronic hepatitis B (CHB). The study specifically investigated long-term HBsAg ki
Externí odkaz:
https://doaj.org/article/415b38de27784d988b5083a1ef4ab88c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
DENG Yanqing, WAN Zhiting, HUANG Boquan, LIANG Haojian, DU Rongsong, LI Zhongping, ZHENG Jianting, XU Ru, WANG Min, WANG Hao
Publikováno v:
Zhongguo shuxue zazhi, Vol 37, Iss 11, Pp 1301-1306 (2024)
[Objective] To analyze the influence of the cycle length of hepatitis B surface antigen (HBsAg) double reagent positive samples collected from voluntary blood donors in Guangzhou on the detection results. [Methods] A total of 127 044 blood samples fr
Externí odkaz:
https://doaj.org/article/a1aae9ea48a14ef8a62e687e261904d1
Publikováno v:
Virology Journal, Vol 21, Iss 1, Pp 1-14 (2024)
Abstract Background Hepatitis B surface antigen (HBsAg) loss is regarded as a pivotal criterion for assessing functional cure in patients diagnosed chronic hepatitis B (CHB). We conducted the research to investigate the real-world performance of HBsA
Externí odkaz:
https://doaj.org/article/55082c31e9ca4210a6a6d7c33eaec95e
Autor:
Xiaodi Li, Ling Xu, Lianfeng Lu, Xiaosheng Liu, Yang Yang, Yuanni Wu, Ting Zhu, Xiaoxia Li, Yanling Li, Xiaojing Song, Yang Han, Wei Lyu, Wei Cao, Taisheng Li
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-12 (2024)
Abstract Background Several studies have reported that combination antiretroviral therapy (cART) enhances the hepatitis B surface antigen (HBsAg) clearance rate in Human Immunodeficiency Virus-1/Hepatitis B Virus (HIV/HBV) coinfected patients, yet th
Externí odkaz:
https://doaj.org/article/adfd764866b3485c804265ba9299c141